Trade Sino Biopharmaceutical Limited - 1177 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021671% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000247% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 100 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.78 |
| Open | 2.82 |
| 1-Year Change | -4.73% |
| Day's Range | 2.8 - 2.92 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 2.88 | 0.10 | 3.60% | 2.78 | 2.92 | 2.78 |
| Jan 16, 2025 | 2.78 | -0.08 | -2.80% | 2.86 | 2.90 | 2.70 |
| Jan 15, 2025 | 2.84 | -0.02 | -0.70% | 2.86 | 2.88 | 2.82 |
| Jan 14, 2025 | 2.84 | 0.02 | 0.71% | 2.82 | 2.86 | 2.82 |
| Jan 13, 2025 | 2.82 | 0.02 | 0.71% | 2.80 | 2.82 | 2.74 |
| Jan 10, 2025 | 2.84 | -0.10 | -3.40% | 2.94 | 2.96 | 2.84 |
| Jan 9, 2025 | 2.96 | -0.04 | -1.33% | 3.00 | 3.00 | 2.94 |
| Jan 8, 2025 | 2.96 | -0.02 | -0.67% | 2.98 | 3.00 | 2.92 |
| Jan 7, 2025 | 3.00 | -0.02 | -0.66% | 3.02 | 3.04 | 2.96 |
| Jan 6, 2025 | 3.02 | -0.04 | -1.31% | 3.06 | 3.08 | 3.02 |
| Jan 3, 2025 | 3.02 | -0.04 | -1.31% | 3.06 | 3.10 | 3.02 |
| Jan 2, 2025 | 3.06 | -0.08 | -2.55% | 3.14 | 3.16 | 3.06 |
| Dec 31, 2024 | 3.20 | 0.00 | 0.00% | 3.20 | 3.22 | 3.16 |
| Dec 30, 2024 | 3.22 | 0.02 | 0.63% | 3.20 | 3.28 | 3.20 |
| Dec 27, 2024 | 3.22 | 0.00 | 0.00% | 3.22 | 3.26 | 3.18 |
| Dec 24, 2024 | 3.24 | 0.02 | 0.62% | 3.22 | 3.24 | 3.18 |
| Dec 23, 2024 | 3.20 | 0.02 | 0.63% | 3.18 | 3.22 | 3.16 |
| Dec 20, 2024 | 3.20 | 0.00 | 0.00% | 3.20 | 3.22 | 3.18 |
| Dec 19, 2024 | 3.20 | 0.04 | 1.27% | 3.16 | 3.22 | 3.14 |
| Dec 18, 2024 | 3.18 | 0.04 | 1.27% | 3.14 | 3.20 | 3.14 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Sino Biopharmeceutical Company profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.| Industry: | Pharmaceuticals (NEC) |
湾仔港湾道1号会展广场辨公大楼41楼09室
HK
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com